
Fredun Pharmaceuticals Ltd. (FREDUN) Pharmaceuticals Share Price Near Record High as Stock Holds Firm
Updated: 20 Nov 2026 • 9:26 am
Posted by:

Fredun Pharmaceuticals Share Price is Rs 1,712, up 0.25%, and trading near a record zone with a market capitalisation of Rs 2,798.83 crore. According to latest Univest data, the move is price-led and the latest figures do not establish a company-specific catalyst.
Fredun Pharmaceuticals Share Price is Rs 1,712, and Fredun Pharmaceuticals Share Price Today is up 0.25% from the previous close of Rs 1,707.7. The stock is trading close to its record zone while the company’s market capitalisation stands at Rs 2,798.83 crore. For Fredun Pharmaceuticals Ltd., the latest Univest data confirms an event-driven price move, but it does not establish a company-specific catalyst. That makes Fredun Pharmaceuticals Stock News relevant for readers tracking both the share price update and the valuation backdrop. The stock’s placement near its peak range also keeps Fredun Pharmaceuticals Share Price on watch in the Indian Stock Market, especially for investors comparing price action with fundamentals and sector context.
Fredun Pharmaceuticals Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,712 |
| Previous Close | Rs 1,707.7 |
| Today's Move | +Rs 4.3 (+0.25%) |
| Open | Rs 1,712 |
| High | Rs 1,730.8 |
| Low | Rs 1,704.95 |
| Market Capitalisation | Rs 2,798.83 crore |
Fredun Pharmaceuticals Ltd. (FREDUN) traded at Rs 1,712 versus the previous close of Rs 1,707.7, a rise of 0.25%. The stock opened at Rs 1,712, reached a high of Rs 1,730.8 and touched a low of Rs 1,704.95.
Fredun Pharmaceuticals Share Price Today opened at Rs 1,712, matched the opening level at the current reading, touched a high of Rs 1,730.8 and a low of Rs 1,704.95. The day change stands at Rs 4.3, or 0.25%, versus the previous close of Rs 1,707.7. That places Fredun Pharmaceuticals Share Price inside a narrow intraday band of Rs 25.85, with the stock remaining close to its upper range as of 20 November 2026 at 9:24:28 AM IST.
The main point for Fredun Pharmaceuticals Share Price Today is that the move is modest in percentage terms while price remains near the upper end of the day’s range. The current level also keeps Fredun Pharmaceuticals Share Price in the spotlight for Stocks in News and 52 Week High Stocks searches, even though the latest Univest figures do not point to a specific trigger. For readers following Fredun Pharmaceuticals Share News, this is a case where the near record zone itself is the event. That sets up the next question around whether the stock’s broader valuation profile supports this price level.
Fredun Pharmaceuticals Ltd. (FREDUN) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 2,798.83 crore |
| P/E Ratio | 55.22x |
| P/B Ratio | 8.44x |
| ROE | 16.09% |
| ROCE | 21.34% |
| EPS | Rs 30.93 |
| Book Value Per Share | Rs 202.35 |
| Dividend Yield | 0.01% |
Fredun Pharmaceuticals Ltd. (FREDUN) fundamental metrics show P/E 55.22x, P/B 8.44x, ROE 16.09%, ROCE 21.34%. These figures provide context only and are not a buy or sell signal.
Fredun Pharmaceuticals Ltd. has a market capitalisation of Rs 2,798.83 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 55.22x, P/B at 8.44x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 16.09% and ROCE of 21.34%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 30.93, book value per share of Rs 202.35, dividend yield of 0.01%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 30.79x, median ROE of 11.23%, median ROCE of 13.1%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 55.22x |
| Benchmark Median P/E | 30.79x |
| Benchmark Average P/E | 59.37x |
| Benchmark P/E Range | 2.73x to 1,399.41x |
| Company P/B Ratio | 8.44x |
| Benchmark Median P/B | 2.85x |
| Company ROE | 16.09% |
| Benchmark Median ROE | 11.23% |
| Company ROCE | 21.34% |
| Benchmark Median ROCE | 13.1% |
| Company Market Capitalisation | Rs 2,798.83 crore |
| Benchmark Median Market Cap | Rs 790.89 crore |
Fredun Pharmaceuticals Ltd. (FREDUN) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Fredun Pharmaceuticals Ltd. (FREDUN) has a P/E ratio of 55.22x, which is above the benchmark median of 30.79x, a difference of +79.34%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Fredun Pharmaceuticals Ltd. (FREDUN) has a ROE of 16.09%, which is above the benchmark median of 11.23%, a difference of +43.28%. Fredun Pharmaceuticals Ltd. (FREDUN) has a ROCE of 21.34%, which is above the benchmark median of 13.1%, a difference of +62.9%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,49,227.49 | 41.64 | 5.11 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,93,873.72 | 88.24 | 16.49 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,76,412.71 | 82.66 | 9.56 | 26.76 | 19.27 |
| Laurus Labs Ltd. | LAURUSLABS | 1,25,460.5 | 92.83 | 20.52 | 18.31 | 18.2 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,19,201.71 | 28.64 | 4.3 | 19.69 | 21.39 |
Fredun Pharmaceuticals Ltd. (FREDUN) has a P/E ratio of 55.22x compared with the displayed peer median of 82.66x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 16.09% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 21.34% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Fredun Pharmaceuticals Ltd. (FREDUN) has a market capitalisation of Rs 2,798.83 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Fredun Pharmaceuticals
- Fredun Pharmaceuticals Share Price is Rs 1,712 and is trading near a record zone as of 20 November 2026 at 9:24:28 AM IST.
- Fredun Pharmaceuticals Share Price Today is up 0.25% from the previous close of Rs 1,707.7.
- Fredun Pharmaceuticals Share Price traded between Rs 1,704.95 and Rs 1,730.8 during the latest session snapshot.
- Fredun Pharmaceuticals Share Price has a P/E ratio of 55.22, a P/B ratio of 8.44 and EPS of Rs 30.93.
- Fredun Pharmaceuticals Share Price shows ROE of 16.09% and ROCE of 21.34% against the same-industry benchmark.
About Fredun Pharmaceuticals
Fredun Pharmaceuticals Ltd. operates in Healthcare and the Pharmaceuticals & Drugs industry. Fredun Pharmaceuticals Share Price is therefore being read in a sector that is benchmarked against a large same-industry universe. The company’s market capitalisation, earnings ratio, book value, return ratios and dividend yield provide the main factual context available for Fredun Pharmaceuticals Stock News today.
For readers checking Fredun Pharmaceuticals Share Price Today, the company profile is best understood through those figures and through the industry and peer comparisons above. Univest uses this approach so Fredun Pharmaceuticals Share Price, Fredun Pharmaceuticals Stock Analysis and Fredun Pharmaceuticals Latest News can be followed from the same factual base.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
What is Fredun Pharmaceuticals Share Price today?
Ans. Fredun Pharmaceuticals Share Price is Rs 1,712 as of 20 November 2026 at 9:24:28 AM IST. It is up 0.25% from the previous close of Rs 1,707.7. The intraday range extended from Rs 1,704.95 to Rs 1,730.8.
Why is Fredun Pharmaceuticals Share Price in focus?
Ans. Fredun Pharmaceuticals Share Price is near a record zone, which naturally draws attention in Stock Market Today searches. The latest Univest figures confirm the price event but do not establish a company-specific catalyst.
How far is Fredun Pharmaceuticals Share Price from the day’s high?
Ans. Fredun Pharmaceuticals Share Price touched Rs 1,730.8 during the latest session snapshot. That places the current price below the day’s high while still staying close to the top of the range.
What does Fredun Pharmaceuticals Share Price tell investors?
Ans. Fredun Pharmaceuticals Share Price reflects a market value of Rs 2,798.83 crore, a P/E ratio of 55.22 and a P/B ratio of 8.44. Those figures frame the stock as a valuation-led story.
Is Fredun Pharmaceuticals Share Price expensive compared with peers?
Ans. Fredun Pharmaceuticals Share Price carries a higher P/E than some peers such as Sun Pharmaceutical Industries Ltd. and Zydus Lifesciences Ltd., but below Divi’s Laboratories, Torrent Pharmaceuticals and Laurus Labs in the listed set.
How do Fredun Pharmaceuticals fundamentals compare with the industry?
Ans. Fredun Pharmaceuticals Share Price is supported by ROE of 16.09% and ROCE of 21.34%, both above the industry medians in the same-industry benchmark. EPS is Rs 30.93 and book value is Rs 202.35.
What is the dividend yield for Fredun Pharmaceuticals Share Price?
Ans. Fredun Pharmaceuticals Share Price is associated with a dividend yield of 0.01%. That is a very small current yield, so the stock’s market view is more closely tied to valuation and earnings metrics.
Where can I track Fredun Pharmaceuticals Share Price live?
Ans. Fredun Pharmaceuticals Share Price can be tracked on Univest, along with live price updates, key ratios, sector context and peer comparison. Univest also helps readers follow Fredun Pharmaceuticals Stock News and Fredun Pharmaceuticals Share News.
Track Fredun Pharmaceuticals Share Price on Univest
Use Fredun Pharmaceuticals Ltd. (FREDUN) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
You can track Fredun Pharmaceuticals Share Price on Univest for live price updates, key ratios, sector context, peer comparison and major market levels. Univest also helps readers follow Fredun Pharmaceuticals Share Price Today, Fredun Pharmaceuticals Share News and Fredun Pharmaceuticals Stock News in one place.
For investors scanning Fredun Pharmaceuticals Share Price Live, Univest presents the latest market capitalisation, valuation ratios, earnings metrics and the company’s position within Healthcare. That makes Fredun Pharmaceuticals Share Price easier to monitor alongside Fredun Pharmaceuticals Latest News and Fredun Pharmaceuticals Stock Analysis.
Recent Articles

Vertoz Ltd. (VERTOZ) Share Price Rises 8.23% Today on Market Update
20 November 2026

SG Mart Ltd. (SGMART) Share Price Near All-Time High as Stock Trades at Rs 1,031.40
20 November 2026

KALPATARU (KALPATARU) Share Price Rises 8.81% Today as Realty Valuation Stays in Focus
20 November 2026

CreditAccess Grameen Ltd. (CREDITACC) 52 Week Low Streak Extends to Second Straight Session
20 November 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Vertoz Ltd. (VERTOZ) Share Price Rises 8.23% Today on Market Update
SG Mart Ltd. (SGMART) Share Price Near All-Time High as Stock Trades at Rs 1,031.40
KALPATARU (KALPATARU) Share Price Rises 8.81% Today as Realty Valuation Stays in Focus
CreditAccess Grameen Ltd. (CREDITACC) 52 Week Low Streak Extends to Second Straight Session
Tata Technologies Share Price Jumps 7% to Rs 704 as FY30 Plan Targets $1.1 to $1.3 Billion Revenue, With JPMorgan's Rs 660 Target Below the Market

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





